Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20140365Phase 2Active
A Phase 2 trial of metakavir in Chronic Hepatitis B (CHB), sponsored by Nanjing Chang'ao Pharmaceutical Technology. Started Apr 2015; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20140365.